Ebos ready for growth

Press, 9 August 1985, Page 8

Ebos ready for growth

The medical industry has significant growth potential in New Zealand, says the chairman of Ebos Dental and Surgical Supplies, Ltd, Mr J. R. Maddren, in the annual report. New Zealand’s population is ageing and there is a greater emphasis on health care. To allow for growth, the directors are recommending an increase in the authorised capital of the company from $1 million to S3M, he says. As reported, the group net

profit rose 16.8 per cent to $601,171 in the year to March 31, compared with the previous corresponding period. Sales increased 28.1 per cent to $11,392,835, and the cost of sales was 29.4 per cent higher at $10,292,042. The result was after providing $73,947 more for tax at $499,622 and $65,352 more for depreciation at $138,372. A recommended final dividend of 6.25 c a share gives a steady annual rate of 11.25 c a

share (22.5 per cent) on capital increased by the one-for-eight bonus issue last August. The dividend requirement is $184,613 and it is covered 3.3 times by the profit. Shareholders’ funds improved $416,558 to $3,493,901, including ordinary capital up $91,068 to $820,505 after the bonus issue.

Working capital rose $234,829 to $2,835,048, but the current ratio eased from 3.0 to 2.2 to one.